CD274 and neoplasm: Among the myeloid subsets in the bone marrow, dual IPI-549/PD-L1 treatment significantly increased the proportion of dendritic cells in tumor-bearing mice relative to single treatment and vehicle controls and was comparable to the proportions in nontumor-bearing control mice (Figure 5C).